Clinical Data, Inc. (NASDAQ: CLDA), today announced that Drew Fromkin,
President and Chief Executive Officer, will be presenting a corporate
overview at the Eighth Annual JMP Securities Research Conference on
Tuesday, May 19, 2009 at the Ritz-Carlton Hotel, San Francisco. Clinical
Data’s presentation will take place at 8:30 a.m. PDT.
A live audio and archived webcast of the Company presentation can be
accessed through the Company’s website at www.clda.com.
About Clinical Data, Inc.
Clinical Data is a global biotechnology company unlocking the potential
of genomic discovery, From Targeted Science to Better Healthcare®.
The Company is utilizing its biomarker expertise and intellectual
property to develop and commercialize targeted therapeutics, as well as
genetic and pharmacogenomic tests to detect serious diseases and help
predict drug safety, tolerability, and efficacy, thereby improving
health while reducing costs. Clinical Data is leveraging advances in
molecular discovery to provide tangible benefits for patients,
healthcare professionals and payors worldwide. To learn more, please
visit the Company's website at www.clda.com.
Clinical Data, Inc.
Theresa McNeely, 617-527-9933 x 3373
Vice
President
Corporate Communications
